BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27983561)

  • 1. Risk Factors for Suicidal Ideation in People at Risk for Huntington's Disease.
    Anderson KE; Eberly S; Groves M; Kayson E; Marder K; Young AB; Shoulson I;
    J Huntingtons Dis; 2016 Dec; 5(4):389-394. PubMed ID: 27983561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suicidal ideation and suicidal behavior according to the C-SSRS in a European cohort of Huntington's disease gene expansion carriers.
    van Duijn E; Vrijmoeth EM; Giltay EJ; Bernhard Landwehrmeyer G;
    J Affect Disord; 2018 Mar; 228():194-204. PubMed ID: 29253686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicidal ideation in a European Huntington's disease population.
    Hubers AA; van Duijn E; Roos RA; Craufurd D; Rickards H; Bernhard Landwehrmeyer G; van der Mast RC; Giltay EJ;
    J Affect Disord; 2013 Oct; 151(1):248-58. PubMed ID: 23876196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suicidal ideation and behavior in Huntington's disease: Systematic review and recommendations.
    Kachian ZR; Cohen-Zimerman S; Bega D; Gordon B; Grafman J
    J Affect Disord; 2019 May; 250():319-329. PubMed ID: 30875675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suicidality in Huntington's disease.
    Hubers AA; Reedeker N; Giltay EJ; Roos RA; van Duijn E; van der Mast RC
    J Affect Disord; 2012 Feb; 136(3):550-7. PubMed ID: 22119091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of suicidal ideation in Huntington's disease: literature review and data from Enroll-HD.
    Honrath P; Dogan I; Wudarczyk O; Görlich KS; Votinov M; Werner CJ; Schumann B; Overbeck RT; Schulz JB; Landwehrmeyer BG; Gur RE; Habel U; Reetz K;
    J Neurol; 2018 Nov; 265(11):2548-2561. PubMed ID: 30167880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicidal ideation in Huntington disease: the role of comorbidity.
    Wetzel HH; Gehl CR; Dellefave-Castillo L; Schiffman JF; Shannon KM; Paulsen JS;
    Psychiatry Res; 2011 Aug; 188(3):372-6. PubMed ID: 21605914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.
    McGarry A; McDermott MP; Kieburtz K; Fung WLA; McCusker E; Peng J; de Blieck EA; Cudkowicz M;
    Neurology; 2019 Apr; 92(14):e1643-e1651. PubMed ID: 30850442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-pituitary-adrenal axis functioning in Huntington's disease and its association with depressive symptoms and suicidality.
    Hubers AA; van der Mast RC; Pereira AM; Roos RA; Veen LJ; Cobbaert CM; van Duijn E; Giltay EJ
    J Neuroendocrinol; 2015 Mar; 27(3):234-44. PubMed ID: 25565388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suicidal Ideation Assessment in Individuals with Premanifest and Manifest Huntington Disease.
    Wesson M; Boileau NR; Perlmutter JS; Paulsen JS; Barton SK; McCormack MK; Carlozzi NE
    J Huntingtons Dis; 2018; 7(3):239-249. PubMed ID: 30056431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disagreement between self-reported and clinician-ascertained suicidal ideation and its correlation with depression and anxiety severity in patients with major depressive disorder or bipolar disorder.
    Gao K; Wu R; Wang Z; Ren M; Kemp DE; Chan PK; Conroy CM; Serrano MB; Ganocy SJ; Calabrese JR
    J Psychiatr Res; 2015 Jan; 60():117-24. PubMed ID: 25438963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Family History on the Clinical Features of Huntington's Disease.
    Kringlen G; Kinsley L; Aufox S; Rouleau G; Bega D
    J Huntingtons Dis; 2017; 6(4):327-335. PubMed ID: 28984613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical periods of suicide risk in Huntington's disease.
    Paulsen JS; Hoth KF; Nehl C; Stierman L
    Am J Psychiatry; 2005 Apr; 162(4):725-31. PubMed ID: 15800145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suicidality in Huntington's Disease: A Qualitative Study on Coping Styles and Support Strategies.
    Hubers AA; Hamming A; Giltay EJ; von Faber M; Roos RA; van der Mast RC; van Duijn E
    J Huntingtons Dis; 2016 May; 5(2):185-98. PubMed ID: 27258585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific psychiatric manifestations among preclinical Huntington disease mutation carriers.
    Marshall J; White K; Weaver M; Flury Wetherill L; Hui S; Stout JC; Johnson SA; Beristain X; Gray J; Wojcieszek J; Foroud T
    Arch Neurol; 2007 Jan; 64(1):116-21. PubMed ID: 17210818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for suicidal ideations in patients with bipolar disorder.
    Umamaheswari V; Avasthi A; Grover S
    Bipolar Disord; 2014 Sep; 16(6):642-51. PubMed ID: 24467510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do depression and anxiety converge or diverge in their association with suicidality?
    Eikelenboom M; Smit JH; Beekman AT; Penninx BW
    J Psychiatr Res; 2012 May; 46(5):608-15. PubMed ID: 22340981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Course of irritability, depression and apathy in Huntington's disease in relation to motor symptoms during a two-year follow-up period.
    van Duijn E; Reedeker N; Giltay EJ; Eindhoven D; Roos RA; van der Mast RC
    Neurodegener Dis; 2014; 13(1):9-16. PubMed ID: 23948661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicidal behavior in prodromal Huntington disease.
    Fiedorowicz JG; Mills JA; Ruggle A; Langbehn D; Paulsen JS;
    Neurodegener Dis; 2011; 8(6):483-90. PubMed ID: 21659725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hopelessness and Suicidal Ideation among Patients with Depression and Neurotic Disorders Attending a Tertiary Care Centre at Eastern Nepal.
    Pokharel R; Lama S; Adhikari BR
    J Nepal Health Res Counc; 2016 Sep; 14(34):173-179. PubMed ID: 28327682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.